Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × CT-P10 × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 17 Lymphoma, Mantle-Cell 13 Burkitt Lymphoma 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Lymphoma, Follicular 6 Lymphoma, B-Cell, Marginal Zone 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Lymphoma, Non-Hodgkin 4 Lymphoma, B-Cell 4 Hodgkin Disease 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Acute 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Biphenotypic, Acute 3 Blast Crisis 3 Waldenstrom Macroglobulinemia 2 Lymphoma 2 Leukemia, Hairy Cell 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, AIDS-Related 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematologic Neoplasms 1

Interventions

Cyclophosphamide 8 Nivolumab 4 Biopsy 4 fludarabine 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Etoposide 3 Doxorubicin 3 Brentuximab Vedotin 3 sodium-iodide symporter 2 pembrolizumab 2 fludarabine phosphate 2 cemiplimab 2 X-Rays 2 Whole-Body Irradiation 2 Vincristine 2 Rituximab 2 Positron-Emission Tomography 2 Photons 2 Mycophenolic Acid 2 Ipilimumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Cyclosporine 2 CTLA-4 Antigen 2 10-propargyl-10-deazaaminopterin 2 treosulfan 1 talimogene laherparepvec 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡